125 related articles for article (PubMed ID: 8305516)
21. Efficient functionalization of 2',5'-oligoadenylates with sulfur.
Lesiak K; Torrence PF
Bioconjug Chem; 1997; 8(2):199-203. PubMed ID: 9095361
[TBL] [Abstract][Full Text] [Related]
22. Targeting RNA decay with 2',5' oligoadenylate-antisense in respiratory syncytial virus-infected cells.
Cirino NM; Li G; Xiao W; Torrence PF; Silverman RH
Proc Natl Acad Sci U S A; 1997 Mar; 94(5):1937-42. PubMed ID: 9050883
[TBL] [Abstract][Full Text] [Related]
23. Discrimination between ribonuclease H- and ribonuclease L-mediated RNA degradation by 2'-O-methylated 2-5A-antisense oligonucleotides.
Cramer H; Player MR; Torrence PF
Bioorg Med Chem Lett; 1999 Apr; 9(7):1049-54. PubMed ID: 10230638
[TBL] [Abstract][Full Text] [Related]
24. Synthesis and biological activities of a phosphorodithioate analog of 2',5'-oligoadenylate.
Beigelman L; Matulic-Adamic J; Haeberli P; Usman N; Dong B; Silverman RH; Khamnei S; Torrence PF
Nucleic Acids Res; 1995 Oct; 23(19):3989-94. PubMed ID: 7479047
[TBL] [Abstract][Full Text] [Related]
25. 5'-Phosphonate modified oligoadenylates as potent activators of human RNase L.
Lášek T; Petrová M; Košiová I; Šimák O; Buděšínský M; Kozák J; Snášel J; Vavřina Z; Birkuš G; Rosenberg I; Páv O
Bioorg Med Chem; 2022 Feb; 56():116632. PubMed ID: 35078032
[TBL] [Abstract][Full Text] [Related]
26. Nuclease-resistant composite 2',5'-oligoadenylate-3', 5'-oligonucleotides for the targeted destruction of RNA: 2-5A-iso-antisense.
Xiao W; Li G; Player MR; Maitra RK; Waller CF; Silverman RH; Torrence PF
J Med Chem; 1998 Apr; 41(9):1531-9. PubMed ID: 9554886
[TBL] [Abstract][Full Text] [Related]
27. Using fluorescence resonance energy transfer (FRET) for measuring 2-5A analogues ability to activate RNase L.
Cramer H; Geselowitz DA; Torrence PF
Nucleosides Nucleotides; 1999; 18(6-7):1523-5. PubMed ID: 10474231
[TBL] [Abstract][Full Text] [Related]
28. Incorporation of a 4-hydroxy-N-acetylprolinol nucleotide analogue improves the 3'-exonuclease stability of 2'-5'-oligoadenylate-antisense conjugates.
Verheijen JC; van Roon AM; Meeuwenoord NJ; Stuivenberg HR; Bayly SF; Chen L; van der Marel GA; Torrence PF; van Boom JH
Bioorg Med Chem Lett; 2000 Apr; 10(8):801-4. PubMed ID: 10782690
[TBL] [Abstract][Full Text] [Related]
29. Synthesis of 2',5'-oligoadenylate analogs containing an adenine acyclonucleoside and their ability to activate human RNase L.
Ueno Y; Ishihara S; Ito Y; Kitade Y
Bioorg Med Chem Lett; 2004 Sep; 14(17):4431-4. PubMed ID: 15357966
[TBL] [Abstract][Full Text] [Related]
30. Synthesis and biological activity of uronic acid analogues of 2-5A[5'-O-triphosphoryladenylyl(2----5')adenylyl-(2'----5')adenosine].
Kinjo JE; Pabuccuoglu A; Alster DK; Lesiak K; Torrence PF
Drug Des Discov; 1992 Feb; 8(3):241-54. PubMed ID: 1525304
[TBL] [Abstract][Full Text] [Related]
31. Potent gene-specific inhibitory properties of mixed-backbone antisense oligonucleotides comprised of 2'-deoxy-2'-fluoro-D-arabinose and 2'-deoxyribose nucleotides.
Lok CN; Viazovkina E; Min KL; Nagy E; Wilds CJ; Damha MJ; Parniak MA
Biochemistry; 2002 Mar; 41(10):3457-67. PubMed ID: 11876654
[TBL] [Abstract][Full Text] [Related]
32. Endowing RNase H-inactive antisense with catalytic activity: 2-5A-morphants.
Zhou L; Civitello ER; Gupta N; Silverman RH; Molinaro RJ; Anderson DE; Torrence PF
Bioconjug Chem; 2005; 16(2):383-90. PubMed ID: 15769093
[TBL] [Abstract][Full Text] [Related]
33. Phosphorothioate analogues of 2',5'-oligoadenylate. Enzymatically synthesized 2',5'-phosphorothioate dimer and trimer: unequivocal structural assignment and activation of 2',5'-oligoadenylate-dependent endoribonuclease.
Karikó K; Sobol RW; Suhadolnik L; Li SW; Reichenbach NL; Suhadolnik RJ; Charubala R; Pfleiderer W
Biochemistry; 1987 Nov; 26(22):7127-35. PubMed ID: 3427062
[TBL] [Abstract][Full Text] [Related]
34. Potent inhibition of respiratory syncytial virus replication using a 2-5A-antisense chimera targeted to signals within the virus genomic RNA.
Player MR; Barnard DL; Torrence PF
Proc Natl Acad Sci U S A; 1998 Jul; 95(15):8874-9. PubMed ID: 9671772
[TBL] [Abstract][Full Text] [Related]
35. Solid-phase synthesis of 5'-triphosphate 2'-5'-oligoadenylates analogs with 3'-O-biolabile groups and their evaluation as RNase L activators and antiviral drugs.
Thillier Y; Stevens SK; Moy C; Taylor J; Vasseur JJ; Beigelman L; Debart F
Bioorg Med Chem; 2013 Sep; 21(17):5461-9. PubMed ID: 23810677
[TBL] [Abstract][Full Text] [Related]
36. Synthesis and properties of 5'-triphosphoryl 2'-5' oligoadenylates (2-5A), and a general method for synthesis of 3', 5'-bisphosphorylated oligonucleotides.
Ikehara M; Oshie K; Hasegawa A; Ohtsuka E
Nucleic Acids Res; 1981 Apr; 9(8):2003-20. PubMed ID: 7243596
[TBL] [Abstract][Full Text] [Related]
37. Telomerase RNA inhibition using antisense oligonucleotide against human telomerase RNA linked to a 2',5'-oligoadenylate.
Kondo Y; Kondo S
Methods Mol Biol; 2007; 405():97-112. PubMed ID: 18369820
[TBL] [Abstract][Full Text] [Related]
38. Catalytic cleavage of an RNA target by 2-5A antisense and RNase L.
Maitra RK; Li G; Xiao W; Dong B; Torrence PF; Silverman RH
J Biol Chem; 1995 Jun; 270(25):15071-5. PubMed ID: 7797490
[TBL] [Abstract][Full Text] [Related]
39. Phosphorothioate analogues of 2',5'-oligoadenylate. Enzymatic synthesis, properties, and biological activities of 2',5'-phosphorothioates from adenosine 5'-O-(2-thiotriphosphate) and adenosine 5'-O-(3-thiotriphosphate).
Suhadolnik RJ; Lee C; Karikó K; Li SW
Biochemistry; 1987 Nov; 26(22):7143-9. PubMed ID: 3427064
[TBL] [Abstract][Full Text] [Related]
40. Respective role of each of the purine N7 nitrogens of 5'-O-triphosphoadenylyl(2'----5')adenylyl(2'----5')adenosine in binding to and activation of the RNase L of mouse cells.
Jamoulle JC; Lesiak K; Torrence PF
Biochemistry; 1987 Jan; 26(2):376-83. PubMed ID: 3030408
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
